| 查看: 957 | 回复: 10 | |||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | |||
[交流]
邀稿 （糖尿病足相关）（Frontiers in Pharmacology，中科院二区top ）
|
|||
|
最近受邀搞一个特刊，有关于糖尿病足，具体内容如下： 期刊名：Frontiers in Pharmacology （中科院分区：二区top） 切记：OA期刊 （文章接受后需要交版面费） 内容：与糖尿病足相关（研究，综述，临床研究报告等均可） 欢迎大家来搞。 Diabetes is a complex metabolic disease that affects more than 340 million individuals worldwide. Around 20% of these patients develop diabetic wounds. Diabetic foot ulcers (DFUs) are a common complication of diabetes that are recalcitrant to healing due to persistent inflammation. Only one FDA-approved medicine, becaplermin, is used to treat DFUs, but it is not the first-line therapy because of its low efficacy and higher risk of cancer and mortality. The absence of effective and safe treatment has necessitated the development of more effective medications or procedures. The mechanism underlying this process, however, remains unknown, prompting further research into diabetic foot ulcer etiology. The development of diabetic wounds is a serious complication for patients with diabetes. Peripheral neuropathy, foot deformity, external trauma, peripheral vascular disease, and peripheral oedema are just a few of the contributing elements that lead to foot ulcers in diabetic individuals. Infection is widespread in DFUs, resulting in the patient’s protracted hospitalization and psychological issues. A better understanding of pathogenic variables can aid in the development of innovative treatments for poor healing. The aim of this Research Topic is to provide a forum focusing on the pathogenesis of DFUs. An understanding of the critical pathways involved will guide future therapies against DFUs. Studies investigating contributing factors of diabetic foot in vitro and in vivo, as well as human clinical samples, are encouraged to accelerate the development of innovative therapies and drugs. Manuscripts relating to DFUs focusing on, but are not limited to, the following topics are invited in this Research Topic: • Identification of new biological pathways and mechanisms • Clinical data sets • Therapeutic regimens for the management of DFUs |
回复此楼» 猜你喜欢
建议基金发布提前给出明确的时间点
已经有14人回复
-
范进中举一文的中心思想
已经有5人回复
-
2026国自然函评费到账
已经有17人回复
-
让我中一个面上吧！
已经有15人回复
-
2026年的国家社科基金项目通讯评审的新规则与新动向、新挑战
已经有5人回复
-
跳槽后在研项目怎么办？
已经有10人回复
-
什么时候开奖？
已经有10人回复
-
今天放榜吗？
已经有16人回复
-
93BebMhtakh前后11位开头都是大写
已经有8人回复
-
只有每年这种时候来逛逛小木虫
已经有26人回复
» 抢金币啦！回帖就可以得到:
-
基金祈福
+1/963
-
散金祈福
+3/783
-
华西生物制药研究院招聘科研助理
+2/400
-
基金申请小调查！预祝申请必定中中中！！祈福！！！
+5/245
-
诚征另一半
+1/170
-
上海交通大学张航课题组招聘博士后（电化学储能）
+1/89
-
美国University of Texas at Arlington土木结构工程方向2027年春季全奖博士招生
+1/86
-
中国药科大学博士，博后招聘（高分子，金属有机方向），欢迎大家交流推荐
+1/84
-
Polymers 期刊特刊 组稿
+1/75
-
焦虑
+1/64
-
坐标南京
+1/30
-
瑞典-博后-固态电池-粘结剂-锂离子电池方向
+1/25
-
南京理工大学优青团队催化化学方向招收推免研究生
+1/22
-
***大叔找对象（沪深等地）
+1/20
-
流放岭南浮肿了求救
+1/20
-
北理工集成电路杰青团队 | 诚招科助理
+1/18
-
北京理工大学-集成电路与电子学院杰青团队-招博士后
+1/17
-
中科院大连化学物理研究所 招聘 催化剂研发方向 科研助理 2名
+1/5
-
出全新蔡司 Plan?APOCHROMAT 20×/0.8 平场复消色差物镜
+1/2
-
找女友
+1/1
4楼2022-08-10 21:54:19
10楼2022-08-10 22:31:47
简单回复
yuekong8楼
2022-08-10 22:12
回复
tzynew2楼
2022-08-10 21:49
回复
basin_2011(金币+1): 谢谢参与
o 发自小木虫Android客户端
2022-08-10 21:59
回复
bjdxyxy5楼
2022-08-10 21:55
回复
basin_2011(金币+1): 谢谢参与
。 发自小木虫Android客户端
飞雪天刘3楼
2022-08-10 21:53
回复
basin_2011(金币+1): 谢谢参与
。 发自小木虫Android客户端
人间失落9楼
2022-08-10 22:21
回复
basin_2011(金币+1): 谢谢参与
！ 发自小木虫Android客户端
